Author

R. Alemany

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. M. Acosta-Moreno· 1 shared A. Mendez-Perez· 1 shared A. Munoz-Barrutia· 1 shared C. Fillat· 1 shared C. O. S. Sorzano· 1 shared C. Wert-Carvajal· 1 shared D. Medel· 1 shared E. Nunez-Manchon· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. M. Acosta-Moreno

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction

A. Mendez-Perez, A. M. Acosta-Moreno, C. Wert-Carvajal, P. Ballesteros-Cuartero, R. Sanchez-Garcia, J. R. Macias, R. Sanz-Pamplona, R. Alemany, C. O. S. Sorzano, A. Munoz-Barrutia, E. Veiga

This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.

bioRxiv · Nov 22, 2023Immunology

Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses

E. Nunez-Manchon, M. Farrera-Sal, G. Castellano, D. Medel, R. Alemany, E. Villanueva, C. Fillat

This study shows that transgene codon usage affects viral fitness and oncolytic efficacy in adenoviruses, with suboptimal codons enhancing sustained expression and therapeutic activity.

bioRxiv · Jun 19, 2020Bioengineering